The COVID-19 Pandemic has been awful. We are living through our hundred year plague and it has been wearing on the hearts and minds of billions.
But, so far, one thing has been consistent. The science has continually proven right in time. It was predicted near the beginning of the Pandemic that it would spread rapidly around the globe, that there would be a second wave in the fall, and then that there would be a vaccine roughly a year, to a year and a half, after the outbreak.
Here we are around 11 months later and there is light at the end of the tunnel. Vaccines are in development which could see wide spread release in the next half a year.
One of the potential vaccines comes in part thanks to someone who has been showing up a lot lately. In recent weeks, Dolly Parton has brought us a Christmas album, a book, a movie, and TV specials. Well, now, thanks to the Dolly Parton COVID-19 Research Fund in support of the Vanderbilt University Medical Center; she might be bringing us a vaccine!
Moderna Therapeutics has become the second company to report promising preliminary results from large trial testing of a coronavirus vaccine. Their study showed it was 94.5% effective, which is incredibly impressive for an early stage vaccine.
Moderna’s efforts to clinch a vaccine were funded, in part, by that same Dolly Parton COVID-19 Research Fund, according to an article published in the New England Journal of Medicine. The Vanderbilt University Medical Center was one of several key players and institutions in public health that have supported Moderna’s efforts.
When the news that the second potential vaccine was partly-funded by Dolly Parton spread, it become a glimmer of hope on Twitter.
At the start of the coronavirus pandemic, Vanderbilt University surgeon Naji Abumrad, who Dolly became friends with after a car accident in 2013, showed Parton the research the university was doing on antibodies to combat COVID-19, and she wanted to help. She went onto donate a million dollars to the Vanderbilt Vaccine Center earlier this year, which is researching synthetic antibodies that could treat and even prevent the virus.
She didn’t need any more than the research, her friend, and faith to know that she could possibly do something to help. Dolly is a person who loves God and her neighbour in a big way. And she’s your Good News Story of the Day. Read it all here.
There are still months to go before the vaccine becomes widely available to the public, requiring government approval, and a crucial peer-review. But there is light at the end of the tunnel. Thanks be to God.
Story and Image from uk.news.yahoo.com